Dendritic Cell Sarcoma

This is a very rare type of cancer that starts in special cells called dendritic cells. These cells are found in your lymph nodes (part of your immune system) and sometimes in other parts of your body. It's a slow-growing cancer, but it can spread if not treated.

Condition

What people with Dendritic Cell Sarcoma report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Dendritic Cell Sarcoma

What It Is

Interdigitating dendritic cell sarcoma is a very rare cancer that starts in interdigitating dendritic cells, immune cells that sit mainly in lymph nodes and help alert the body's T cells to infections and other threats. It most often appears as a painless, enlarged lymph node, commonly in the neck or armpit. Some people also have fever, night sweats, tiredness or weight loss. The cancer can also begin outside the lymph nodes, for example in the liver, skin, spleen or tonsils. It can behave slowly in some people and aggressively in others, and it often spreads to distant organs. It is a different disease from follicular dendritic cell sarcoma and Langerhans cell conditions, which have similar names.

Causes & Risk Factors

The cause is not known. It occurs mostly in adults, usually in later middle age, and slightly more often in men. About one in five people with this sarcoma have, or have had, another cancer, most notably certain B-cell lymphomas. In some of these cases the sarcoma appears to have developed from the lymphoma cells themselves. No lifestyle factor or inherited risk has been established.

How It's Diagnosed

Diagnosis requires a biopsy, in which a sample or the whole affected lymph node is removed and examined. Under the microscope the cells can resemble other cancers, including lymphoma and melanoma, so pathologists use special stains that detect proteins on the cells. No single result defines the disease; it is diagnosed by a characteristic staining pattern that rules out look-alikes, and review by a pathologist experienced in rare lymph node tumors is valuable. Imaging scans then show whether the disease is limited to one area or has spread.

Treatment Options

Because the disease is so rare, there is no agreed standard treatment, and most of what is known comes from individual case reports. When the tumor is limited to one area, surgery to remove it completely is the main approach, and in pooled reports it is the only treatment linked to longer survival. Radiation is sometimes used when surgery is not possible. When the cancer has spread, chemotherapy, often with drug combinations used for lymphoma, is the usual choice, though benefit is often limited. A few people have received a stem cell transplant, and some tumors carry genetic changes that may make a targeted drug or clinical trial worth discussing.

What to Expect

The outlook depends mostly on whether the cancer has spread. In a review of 127 published cases, about one in five people with localized disease died within a year, compared with nearly four in five when the disease had spread. Some people treated with surgery for a single tumor remain free of disease for years, and because these figures come from scattered reports, an individual's course can differ. Care is usually led by a cancer center experienced in rare tumors, with regular follow-up visits and scans afterward, since the disease often returns or spreads.

When to Seek Help

See a clinician if a lump or swollen lymph node lasts more than a few weeks, keeps growing or comes with fever, drenching night sweats or unexplained weight loss. After a diagnosis, contact your care team about a new lump, new pain or returning fevers and sweats.

Questions to Ask Your Doctor

  1. 1.Has the biopsy been reviewed by a pathologist experienced in rare dendritic cell tumors?
  2. 2.Is the cancer limited to one area, and can it be removed completely with surgery?
  3. 3.If it has spread, what are the realistic goals of chemotherapy or other treatment?
  4. 4.Should the tumor be tested for genetic changes that could open up a targeted drug or clinical trial?
  5. 5.How often will I need scans and follow-up visits after treatment?

Last reviewed • Oct 2026

Educational content, not medical advice.